SCHEMBL29828855

SCHEMBL29828855

O=C(O)c1ccc[nH]ccnccncccncc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NAPRT Q6XQN6 2/20 0.59
▸ ALDH1A1 P00352 2/20 0.49
▸ CYP1A2 P05177 2/20 0.49
▸ CYP3A4 P08684 2/20 0.49
▸ CYP2D6 P10635 2/20 0.49
▸ CYP2C19 P33261 2/20 0.49
▸ PLOD2 O00469 2/20 0.49
▸ PLOD3 O60568 1/20 0.49
▸ CYP2C9 P11712 1/20 0.49
▸ HPGD P15428 1/20 0.49
▸ PLOD1 Q02809 1/20 0.49
▸ HIF1A Q16665 1/20 0.49
▸ MEN1 O00255 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ APP P05067 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ HCAR3 P49019 1/20 0.47
▸ HCAR2 Q8TDS4 1/20 0.47
▸ DAO P14920 1/20 0.43
▸ TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isonicotinic Acid SCHEMBL28136907 0.87 NAPRT (0.71) NAPRTALDH1A1CYP1A2CYP3A4CYP2D6
Benzoic Acid SCHEMBL28033008 0.79 NAPRT (0.48) NAPRTALDH1A1CYP1A2CYP3A4CYP2D6
Isonicotinic Acid SCHEMBL8358038 0.79 NAPRT (0.85) NAPRTALDH1A1CYP1A2CYP3A4CYP2D6
Benzoic Acid SCHEMBL2514951 0.77 NAPRT (0.74) NAPRTALDH1A1CYP1A2CYP3A4CYP2D6
Isonicotinic Acid SCHEMBL1414914 0.77 NAPRT (1.00) NAPRTALDH1A1CYP1A2CYP3A4CYP2D6
Isonicotinic Acid SCHEMBL1108 0.77 — —
Benzoic Acid SCHEMBL5323571 0.77 NAPRT (0.54) NAPRTALDH1A1CYP1A2CYP3A4CYP2D6
Niacin SCHEMBL5485587 0.75 ALDH1A1 (0.78) NAPRTALDH1A1CYP1A2CYP3A4CYP2D6
Benzoic Acid SCHEMBL2514725 0.75 NAPRT (0.70) NAPRTALDH1A1CYP1A2CYP3A4CYP2D6
Benzoic Acid SCHEMBL3811105 0.75 NAPRT (0.70) NAPRTALDH1A1CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240208992-A1 MACROCYCLES AS CFTR MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2024-06-27 — — US disclosed
EP-4308575-A1 MACROCYCLES AS CFTR MODULATORS Idorsia Pharmaceuticals Ltd (CH) 2024-01-24 — — EP disclosed
WO-2022194399-A1 MACROCYCLES AS CFTR MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2022-09-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240208992-A1 MACROCYCLES AS CFTR MODULATORS CFTR, PKD1, ARRB1 NAPRT 4011/4885ALDH1A1 2257/4885CYP1A2 862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback